Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2012
10/11/2012WO2012136552A1 ANTIBODIES SPECIFIC TO PYROGLUTAMATED Αβ
10/11/2012WO2012136534A2 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
10/11/2012WO2012136522A1 Antibody product comprising n specific antibodies
10/11/2012WO2012136519A1 Use of neutralizing prolactin receptor antibodies for the treatment and prevention of antiestrogen-resistant breast cancer
10/11/2012WO2012136250A1 Hmgb1 specific monoclonal antibodies
10/11/2012WO2012136172A1 Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
10/11/2012US20120260354 Use of K2P Potassium Channel Activators as Antalgics
10/11/2012US20120259097 Use of anti-factor xi antibodies for prevention of thrombus formation
10/11/2012US20120259096 Antibodies to ion channels
10/11/2012US20120259095 Monoclonal antibodies with enhanced adcc function
10/11/2012US20120258998 Fusion genes in gastrointestinal cancer
10/11/2012US20120258887 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same
10/11/2012US20120258872 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
10/11/2012US20120258865 Mirac proteins
10/11/2012US20120258550 Regulation of autophagy pathway phosphorylation and uses thereof
10/11/2012US20120258519 Protein Harvesting
10/11/2012US20120258458 Interferon-like protein zcyto21
10/11/2012US20120258309 Diagnostic gel composition, method for making a diagnostic gel composition
10/11/2012US20120258122 Antibodies Directed to Angiopoietin-1 and Angiopoietin-2 and Uses Thereof
10/11/2012US20120258121 Generation of anti-fn14 monoclonal antibodies by ex-vivo accelerated antibody evolution
10/11/2012US20120258120 Compositions and methods for the systemic treatment of arthritis
10/11/2012US20120258119 Anti-fibroblast activation protein antibodies and methods and uses thereof
10/11/2012US20120258118 Antibody therapeutics with local activity in the digestive tract
10/11/2012US20120258117 Methods and compositions for modulation of histone ubiquitination
10/11/2012US20120258115 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
10/11/2012US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
10/11/2012US20120258112 Antibodies against human ccn1 and uses thereof
10/11/2012US20120258111 Compositions and methods for modulating rsv infection and immunity
10/11/2012US20120258109 Antibodies that bind tgf-alpha and epiregulin
10/11/2012US20120258108 Dual Variable Domain Immunoglobulins and Uses Thereof
10/11/2012US20120258107 Agents, Uses and Methods
10/11/2012US20120258106 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
10/11/2012US20120258102 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibodies
10/11/2012US20120258101 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/11/2012US20120258100 Chimeric anti-ricin antibody
10/11/2012US20120258097 Methods of using btl-ii proteins
10/11/2012US20120258096 Anti-d monoclonal antibodies
10/11/2012US20120258091 Genetic products differentially expressed in tumors and the use thereof
10/11/2012US20120258041 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012US20120258040 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
10/11/2012DE102011006781A1 Antikörperprodukt, umfassend n spezifische Antikörper Antibody product comprising n-specific antibodies
10/11/2012CA2835606A1 Single chain antibodies for photosynthetic microorganisms and methods of use
10/11/2012CA2832738A1 Herpes simplex virus
10/11/2012CA2832665A1 Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
10/11/2012CA2832540A1 Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
10/11/2012CA2832373A1 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
10/11/2012CA2832281A1 Anti-cd154 antibodies having impaired fcr binding and/or complement binding properties and the use thereof in immune therapies
10/11/2012CA2832256A1 Antibodies that bind tgf-alpha and epiregulin
10/11/2012CA2832187A1 Methods for treating conditions associated with masp-2 dependent complement activation
10/11/2012CA2832106A1 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012CA2831957A1 Novel egfr binding proteins
10/11/2012CA2831751A1 Novel anti-human il-23 receptor antibody
10/11/2012CA2828890A1 Anti-fgfr4 antibodies and methods of use
10/10/2012EP2508887A1 Method for detecting microorganisms belonging to mycoplasma pneumoniae and/or mycoplasma genitalium
10/10/2012EP2508602A1 Susceptibility gene for hair shapes
10/10/2012EP2508596A2 MN/CA IX-specific monoclonal antibodies generated from MN/CA IX-deficient mice and methods of use
10/10/2012EP2508536A1 Cytotoxicity mediation of cells evidencing surface expression of CD44
10/10/2012EP2507265A2 Novel heparanase splice variant
10/10/2012EP2507264A2 Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid 2)
10/10/2012EP2507263A1 Anti-igf-ir antibodies and uses thereof
10/10/2012EP2507262A1 Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
10/10/2012EP2506877A1 Therapies for preventing or suppressing clostridium difficile infection
10/10/2012EP2506876A2 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
10/10/2012EP2506875A1 Methods for treating cancers comprising k-ras mutations
10/10/2012EP2506874A1 Von willebrand factor specific binding agents and uses thereof
10/10/2012EP2506871A1 ANTIBODY Fc MUTANTS WITH ABLATED EFFECTOR FUNCTIONS
10/10/2012EP2506868A2 Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
10/10/2012CN1973053B Novel anti-IL 13 antibodies and uses thereof
10/10/2012CN1694902B Antibody binding with epitope of EphB4 polypeptides and application thereof
10/10/2012CN1522156B Novel engineered superantigen for human therapy
10/10/2012CN1371416B Human CTLA-4 antibodies and their uses
10/10/2012CN1359301B Pharmaceutical composition comprising antibody specifically binding epitope in A-beta-10 residual group and its application
10/10/2012CN102725310A Isoform specific anti-HER4 antibodies
10/10/2012CN102725309A Novel antagonist antibodies and their Fab fragments against GPVI and uses thereof
10/10/2012CN102725304A Wash solution and method for affinity chromatography
10/10/2012CN102725002A Agents, uses and methods
10/10/2012CN102725000A Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (IGF-1R)
10/10/2012CN102719444A Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
10/10/2012CN102719443A Carboxyl-terminal specific anti-human amyloid protein monoclonal antibody gene and its encoded polypeptide and application
10/10/2012CN102719441A Preparation method of antibody of trichina antigen gene TS498 associated to breast cancer
10/10/2012CN102719406A Monoclonal antibody resistant to nephropathogenic avian infectious bronchitis virus strain DS10
10/10/2012CN102719405A Hybridoma cell strain 1C8 and anti-aflatoxin G1 monoclonal antibody produced by same
10/10/2012CN102718867A Polypeptide compound for inhibiting angiogenesis and tumor growth
10/10/2012CN102718866A Method for preparing takifugu obscurus source resistant pathogenic aeromonas veronii egg-yolk antibody
10/10/2012CN102718865A Humanized anti-EV71 virus neutralizing antibody EV71FabL11, preparation method and application thereof
10/10/2012CN102718864A Human anti-EV71 (enterovirus 71) neutralizing antibody EV71FabK7 and preparation method and application thereof
10/10/2012CN102718863A H5 subtype specific binding protein capable of diagnosing and monitoring H5 avian influenza
10/10/2012CN102718855A Anti-Pf 332-DBL sectional monoclonal antibody capable of inhibiting invasion of plasmodium falciparum
10/10/2012CN102718840A Human MMP-14 antigen, corresponding monoclonal antibody and application thereof
10/10/2012CN102718670A Ractopamine hapten, artificial antigen and preparation methods for Ractopamine hapten and artificial antigen
10/10/2012CN102718651A Diethylstilbestrol hapten, artificial antigen and preparation methods for diethylstilbestrol hapten and artificial antigen
10/10/2012CN102716476A Cell inactivated vaccine, egg yolk antibody injection, and preparation method of cell inactivated vaccine
10/10/2012CN102093982B H9N2 subtype avian influenza virus strain and application thereof
10/10/2012CN101880322B Co-production process for immune globulin and high-density lipoprotein in poultry egg yolk
10/10/2012CN101863979B Monoclonal antibody capable of resisting chlamys farrei particle blood corpuscle and preparation method thereof
10/10/2012CN101857636B Anti-interferon-alpha antibodies
10/10/2012CN101636179B Antagonists of pcsk9
10/10/2012CN101580544B Colloidal gold labelled monoclonal antibody immunity detection Plate for detecting cannabis and tetrahydrocannabinol
10/10/2012CN101287988B Methods and compositions for diagnosis and treatment of influenza
10/10/2012CN101258165B Humanised antibodies specific for nogo-a and pharmaceutical uses thereof
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 1494